Fortini

United States Clinical Nutrition Market Outlook & Forecast Report 2022-2027 Featuring Key Vendors - Abbott, B. Braun Melsungen, Baxter, Danone, Fresenius Kabi, Nestle, Perrigo, & Reckitt Benckiser - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 24, 2023
Fitness & Nutrition, Health, Reckitt, Government, Obesity, ICU, Patient, US FDA, Food, Effectiveness, Infant, Nutrient, Birth rate, Conditional sentence, Research, Perrigo, Risk, Hypertension, Fresenius (company), Ensure, Fortini, CVD, Prevalence, Danone, COVID-19, AMN, Abbott, Dietary supplement

The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% during 2022-2027.

Key Points: 
  • The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% during 2022-2027.
  • The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market.
  • Clinical nutrition, known as medical nutrition, is the practice of analyzing and identifying whether an individual is consuming an adequate amount of nutrients for health.
  • Abbott's Ensure is one of the leading clinical nutrition products used in the U.S. clinical nutrition market.

United States Clinical Nutrition Market Outlook Report 2022-2027 - Opportunities in Increasing Demand for Infant Nutrition, Advances in Nutritional Therapies, & Shift Toward Home Nutritional Care

Retrieved on: 
Wednesday, January 25, 2023
Conditional sentence, Danone, Food, Perrigo, AMN, Hypertension, CVD, Fortini, Infant, Health, Fresenius (company), Obesity, Nutrient, Government, Birth rate, US FDA, Reckitt, COVID-19, Research, Abbott, Prevalence, Effectiveness, Patient, Risk, Ensure, ICU, Dietary supplement

The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market.

Key Points: 
  • The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market.
  • Personalized clinical nutrition is one of the trending approaches in clinical nutrition to fulfill the nutritional demand of every individual patient suffering from specific conditions.
  • Increasing infant birth rates with lower weight delivers significant industry growth opportunities in milk-based nutritional products for U.S. clinical nutrition market players.
  • Abbott's Ensure is one of the leading clinical nutrition products used in the U.S. clinical nutrition market.

Fortini™ Infant Formula Clears FDA Review; Energy- and Nutrient-dense Formula Aims to Set New Standard in U.S. to Support Growth in Infants with, or at Risk of, Failure to Thrive

Retrieved on: 
Thursday, September 23, 2021
Food, Infant, Clinical trial, Failure, Wake Forest, Review, WIC, Epilepsy, Nutricia North America, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Fortini, Health, FDA, Medicaid, Patient, Wound healing, Lists of diseases, Physician, MD, Malnutrition, WhiteWave Foods, General manager, Growth, Risk, Food allergy, Wake Forest School of Medicine, Weight gain, Parent, Research, Safety, Amino acid-based formula, Department, Bottled water, Birth control

It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.

Key Points: 
  • It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.
  • All formulas marketed in the United States must meet federal nutritional, growth and safety requirements, and infant formula manufacturers must notify the FDA prior to marketing a new formula.
  • Fortini has been shown in clinical trials to be well tolerated and supports weight gain and catch-up growth in failure-to-thrive infants under medical supervision.
  • Until now, there has been no such formula available in the U.S. for term infants with failure to thrive or growth failure.